Clinical Trial: A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07870330) titled 'A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Children' on Oct. 06.

Brief Summary: The purpose of this study is to evaluate safety, reactogenicity, and immunogenicity of mRNA-1010 in healthy children (9 to <18 years of age).

Study Start Date: Oct. 07

Study Type: INTERVENTIONAL

Condition: Seasonal Influenza

Intervention: BIOLOGICAL: mRNA-1010

Suspension for injection

BIOLOGICAL: Fluarix Trivalent

Suspension for injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ModernaTX, Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....